InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Slonin Jonathan, Directeur Clinique. Officer active across 1 company, notably Pacira BioSciences, Inc.. In total, 21 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €447k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Slonin Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
3,040 shares@ US$23.230.0076% mcap6.7% of flowCommon StockSEC:0001628280-26-057759:0
3,261 shares@ US$22.8210.9% of flowCommon StockSEC:0001628280-26-019891:0
54,546 shares0Common StockSEC:0001628280-26-008075:0
6,168 shares@ US$20.5413.4% of flowCommon StockSEC:0001628280-26-005155:0
381 shares@ US$24.461.0% of flowCommon StockSEC:0001628280-26-000968:0
3,960 shares@ US$24.0912.1% of flowCommon StockSEC:0001628280-25-053205:0
315 shares@ US$22.071.1% of flowCommon StockSEC:0001396814-25-000095:0
5,084 shares@ US$26.4022.5% of flowCommon StockSEC:0001396814-25-000067:0
93,600 shares0Common StockSEC:0001396814-25-000033:0
371 shares@ US$18.331.6% of flowCommon StockSEC:0001396814-25-000007:0
305 shares@ US$20.751.4% of flowCommon StockSEC:0001396814-24-000100:0
437.271 shares@ US$24.3192.4% of flowCommon StockSEC:0001396814-24-000088:0
5,012 shares@ US$28.5732.9% of flowCommon StockSEC:0001396814-24-000084:0
1,615 shares@ US$30.8911.3% of flowCommon StockSEC:0001396814-24-000051:0
5,000 shares0Common StockSEC:0001396814-24-000013:0
471 shares@ US$38.9914.2% of flowCommon StockSEC:0001209191-23-035263:0
308 shares@ US$55.704.2% of flowCommon StockSEC:0001209191-22-044554:0
924 shares@ US$57.18812.7% of flowCommon StockSEC:0001209191-22-041521:0
362 shares@ US$61.3742.6% of flowCommon StockSEC:0001209191-22-035232:0
2,000 shares@ US$52.3712.4% of flowCommon StockSEC:0001209191-22-031854:0
5,000 shares0Common StockSEC:0001209191-21-049940:0
21 of 21 declarations
About Slonin Jonathan
SLONIN JONATHAN is Directeur Clinique. He is also Chief Medical Officer at Pacira BioSciences, Inc. (XNAS). The 20 filings on record concern, for the recent sample of 20 filings, disposals, with EUR 0 of purchases and EUR 386515 of sales between 2021-08-05 and 2026-03-19.
